Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 32 | ECE2013 | Next issue

15th European Congress of Endocrinology

Plenary Lectures

Aldosterone, Mineralocorticoid Receptors and Cardiovascular Risk: What's New?

ea0032pl7 | Aldosterone, Mineralocorticoid Receptors and Cardiovascular Risk: What's New? | ECE2013

Aldosterone, mineralocorticoid receptors and cardiovascular risk: what's new?

Funder J

Classically aldosterone acted uniquely on epithelia, and primary aldosteronism (PA) was considered uncommon and relatively benign, all of which we now know to be not the case. In 2013, we should note that:i). Mineralocorticoid receptors (MR) evolved millions of years before aldosterone.ii). Cortisol occupies 90–99% of all MR in the human body.iii). MR are promiscuous, binding cortisol, aldosterone and pr...